期刊文献+

红景天苷对C6胶质瘤细胞系迁移及生长的影响 被引量:5

Effects of salidroside on migration and growth of C6 glioma cell line
下载PDF
导出
摘要 目的:研究红景天苷(salidroside,SLDS)对C6胶质瘤细胞系迁移和生长的影响。方法:通过CCK-8实验和LDH实验确定SLDS作用于C6胶质瘤细胞的最适浓度;通过细胞生长曲线、细胞形态图和划痕实验观察SLDS对C6胶质瘤细胞系生长和迁移的影响;通过Western印迹和qPCR检测C6胶质瘤细胞中MMP-9和周期蛋白A(Cyclin A)的表达水平。结果:CCK-8实验和LDH实验显示在12.5,25,50,100和200μmol/L这5个浓度中,100μmol/L的SLDS对C6胶质瘤细胞的抑制最为显著;细胞形态图和生长曲线显示,加入SLDS后C6胶质瘤细胞的生长被显著抑制;划痕实验显示SLDS组肿瘤细胞侵袭力较对照组明显减弱;Western印迹和qPCR显示SLDS组MMP-9和Cyclin A的表达水平明显低于对照组。结论:SLDS对C6胶质瘤细胞的生长及迁移具有抑制作用。 Objective: To investigate the effects of Salidroside on migration and growth of C6 glioma cell line. Methods: CCK-8 assay and LDH assay were applied to determine the optimal effect concentration of salidroside on C6 glioma cells. Cell growth curve, Cell morphology and Wound scratch assay were carried out to illustrate the influence of salidroside on migration and growth of C6 glioma cells. The expression levels of MMP-9 and Cyclin A in C6 glioma cells were tested by Western blot and qPCR. Results: CCK-8 assay and LDH assay demonstrated that within the scope of 12.5, 25, 50, 100 and 200 μmol/L, 100 μmol/L is the optimal effect concentration of salidroside on C6 glioma cells. Cell growth curve and Cell morphology showed that the growth of C6 glioma cells was suppressed obviously after treated with salidroside. Wound scratch assay revealed that the invasiveness of C6 glioma cells had been attenuated in the SLDS group, and Western blot and qPCR demonstrated that the expression levels of MMP-9 and Cyclin A in the SLDS group were evidently lower than the control group. Conclusion: Salidroside inhibits the growth and migration of C6 glioma cell line.
作者 刘宽 赵富花 张国庆 曾现伟 LIU Kuan ZHAO Fuhua ZHANG Guoqing ZENG Xianwei(Clinical College, Weifang Medical University, Weifang Shandong 261053 Department of Traditional Chinese Medicine, The 95876 Military Hospital of Chinese PLA, Zhangye Gansu 734100 People's Hospital of Gaoxin Weifang, Weifang Shandong 261000 Department of Neurosurgery, Affiliated Hospital of Weifang Medical University, Weifang Shandong 261031, China)
出处 《临床与病理杂志》 2017年第2期257-263,共7页 Journal of Clinical and Pathological Research
基金 山东省自然科学基金(ZR2013HM039)~~
关键词 红景天苷 胶质瘤 基质金属蛋白酶9 周期蛋白A salidroside glioma matrix metalloproteinase 9 Cyclin A
  • 相关文献

参考文献2

二级参考文献38

  • 1Ricard D, Idbaih A, Ducray F, et al. Primary brain tumours in adults. Lancet 2012;379:1984-96.
  • 2Patil CG, Eboli P, Hu J. Management of multifocal and multicentric gliomas. Neurosurg Clin N Am 2012;23:343-50, x.
  • 3Chamberlain MC. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert Rev Neurother 2010;10:1537-44.
  • 4Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine 2011; 18:235-44.
  • 5Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010;17:481-93.
  • 6Englot DJ, Berger MS, Chang EF, et al. Characteristics and treatment of seizures in patients with high-grade glioma: a review. Neurosurg Clin N Am 2012;23:227-35.
  • 7Kim YH, Kim CY. Current surgical management of insulargliomas. Neurosurg Clin N Am 2012;23:199-206, vii.
  • 8Mattox AK, Lark AL, Adamson DC. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy. Clin Neurol Neurosurg 2012; 114:299-306.
  • 9Hasovits C, Clarke S. Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. Clin Pharmacokinet 2 012; 51:2 0 3-2 4.
  • 10Chen T, Stephens PA, Middleton FK, et al. Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today 2012;17:194-202.

共引文献19

同被引文献80

引证文献5

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部